Repaja, Janrey .
HRN: 28-15-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/24/2025
11/30/2025
IV
500mg
Q8
Acute Appendicitis
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines